{{Rsnum
|rsid=1056534
|Gene=FN3K
|Chromosome=17
|position=82750725
|Orientation=plus
|GMAF=0.3632
|Gene_s=FN3K,TBCD
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 21.7 | 41.7 | 36.7
| HCB | 13.3 | 40.0 | 46.7
| JPT | 19.0 | 42.9 | 38.1
| YRI | 6.7 | 45.0 | 48.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 13.3 | 40.0 | 46.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19834870
|Title=A Polymorphism within the Fructosamine-3-kinase Gene is Associated with HbA1c Levels and the Onset of Type 2 Diabetes Mellitus
}}

{{PMID Auto
|PMID=15303240
|Title=Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region.
|OA=1
}}

{{PMID Auto
|PMID=24908234
|Title=Fructosamine 3-kinase and glyoxalase I polymorphisms and their association with soluble RAGE and adhesion molecules in diabetes
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}